Company / Operating Cash Flow per Share
bioAffinity Technologies, Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$13.99
FY2025
5-year range
-$13.99 / -$0.49
FY2022-FY2025
Trend
-2077.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -2077% YoY in FY2025, a notable deviation from the 3-year average annual change of -691%.
Based on SEC 10-K filings.
-13.99 in FY2025.
Declined from $-0.49 to $-13.99 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 2077.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.99 | -2077.3% |
| FY2024 | -$0.64 | -32.3% |
| FY2023 | -$0.49 | +36.5% |
| FY2022 | -$0.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026